BC
MRNA icon

Bartlett & Co’s Moderna MRNA Stock Holding History

Bartlett & Co’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		$31K Sell
310
-70
-18% -$5.89K ﹤0.01% 789
2023
Q3 		$39K Sell
380
-50
-12% -$5.58K ﹤0.01% 706
2023
Q2 		$52K Buy
430
+50
+13% +$6.67K ﹤0.01% 657
2023
Q1 		$58K Sell
380
-50
-12% -$8.25K ﹤0.01% 548
2022
Q4 		$77K Buy
430
+150
+54% +$24.5K ﹤0.01% 508
2022
Q3 		$33K Buy
280
+20
+8% +$3.04K ﹤0.01% 630
2022
Q2 		$37K Sell
260
-50
-16% -$7.15K ﹤0.01% 619
2022
Q1 		$53K Buy
+310
New +$52.2K ﹤0.01% 576

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bartlett & Co's MRNA Position: Q4 2023 in Review

Bartlett & Co reduced its Moderna (MRNA) stake by 18% in Q4 2023, selling an estimated $5.89K and leaving 310 shares worth $31K. The position accounts for ﹤0.01% of the portfolio, ranked #789.

Bartlett & Co first reported a position in MRNA in Q1 2022 and has held it in 8 quarters since. The position peaked at $77K in Q4 2022. 884 funds tracked by Wall St. Rank hold MRNA as of Q4 2023.

  • Bartlett & Co held 310 shares of Moderna worth $31K as of Q4 2023.
  • Bartlett & Co sold 70 Moderna shares in Q4 2023, an estimated $5.89K.
  • Moderna made up ﹤0.01% of Bartlett & Co's portfolio in Q4 2023, its #789 holding.
  • Bartlett & Co first reported a position in Moderna in Q1 2022 and has held it in 8 quarters since.
  • Bartlett & Co's Moderna position peaked at $77K in Q4 2022.
  • 884 funds tracked by Wall St. Rank held Moderna as of Q4 2023.

Based on Bartlett & Co's 13F filing for Q4 2023, filed 8 Jan 2024.